Higher Dose Intradermal H5 Vaccine

NCT00439335 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
227
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)